Technology Foundation to Accelerate
and Scale Product Development

  • Alexion Boehringer Ingelheim CSL Emmes GSK Moderna

“Our strategic partnership with Veeva expands our capacity to leverage innovative technology and enhances our ability to deliver value to patients and all our stakeholders – this is key to how we measure success.”

-Robert M Davis, Chief Executive Officer and President, Merck

Read the Press Release

Greater Efficiency and Innovation

GSK
Standardizing Common Data and Processes Across R&D

Sarepta
Time Savings and Data Consistency with Regulatory and Quality Connection

Argenx
Greater Efficiency and Transparency with Veeva Development Cloud

Merck
Building a Veeva Center of Excellence

LEO
Streamlining Product Development with a Unified Platform

Inhibrx
Deploying an R&D System Foundation in 4.5 Months

Idorsia
Why Idorsia Standardized on Clinical, Quality, and Regulatory

Alexion
Alexion Supports Rapid Growth with Veeva Development Cloud

Boehringer Ingelheim
How Boehringer Ingelheim Deepened its Digital Transformation

Lysarc
LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments

Emmes
Emmes Standardizes on Veeva Development Cloud to Streamline Product Development

Gilead, AbbVie
Best Practices for Bringing Acquired Companies into a Veeva Environment

Interested in learning more about how Veeva can help?